First Time Loading...

ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 62.39 USD -2.16% Market Closed
Updated: May 18, 2024

ANI Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ANI Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Gross Profit
$305.3m
CAGR 3-Years
36%
CAGR 5-Years
19%
CAGR 10-Years
31%
Johnson & Johnson
NYSE:JNJ
Gross Profit
$59.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.6B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$38.8B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$46B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$28.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is ANI Pharmaceuticals Inc's Gross Profit?
Gross Profit
305.3m USD

Based on the financial report for Dec 31, 2023, ANI Pharmaceuticals Inc's Gross Profit amounts to 305.3m USD.

What is ANI Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
31%

Over the last year, the Gross Profit growth was 72%. The average annual Gross Profit growth rates for ANI Pharmaceuticals Inc have been 36% over the past three years , 19% over the past five years , and 31% over the past ten years .